1-s2.0-S1472979215207020-main.pdf (683.17 kB)
Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis
journal contributionposted on 2020-09-03, 10:07 authored by David T Mzinza, Derek J Sloan, Kondwani C Jambo, Doris Shani, Mercy Kamdolozi, Katalin A Wilkinson, Robert J Wilkinson, Geraint R Davies, Robert S Heyderman, Henry C Mwandumba
In HIV-uninfected adults with pulmonary tuberculosis (TB), anti-TB treatment is associated with changes in Mycobacterium tuberculosis (Mtb)-specific immune responses, which correlate with sputum bacillary load. It is unclear if this occurs in HIV-infected TB patients. We investigated changes in Mtb-specific immune responses and sputum bacillary clearance during anti-TB treatment in HIV-infected and HIV-uninfected adults with pulmonary TB. Sputum bacillary load was assessed by smear microscopy and culture. Mtb-specific IFN-γ secreting peripheral blood mononuclear cells were enumerated using an ELISPOT assay following stimulation with PPD, ESAT-6 and CFP-10. The baseline frequency of Mtb-specific IFN-γ secreting cells was lower in HIV-infected than HIV-uninfected patients (median PPD 32 vs. 104 Spot Forming Units (SFU), p = 0.05; CFP-10 19 vs. 74 SFU, p = 0.01). ESAT-6-specific IFN-γ secreting cells and sputum bacillary load declined progressively during treatment in both HIV-infected and HIV-uninfected patients. HIV infection did not influence the 2-month sputum culture conversion rate (Odds Ratio 0.89, p = 0.95). These findings suggest that changes in ESAT-6-specific immune responses during anti-TB treatment correspond with changes in sputum bacillary load irrespective of host HIV infection status. The utility of Mtb-specific IFN-γ responses as a proxy measure of treatment response in HIV-infected TB patients warrants further evaluation in other settings.
Anti-tuberculosis treatmentAntigen-specific immunityHIV infectionIFN-γMycobacterium tuberculosisPulmonary tuberculosisAdultAntitubercular AgentsBacterial LoadCells, CulturedCoinfectionEnzyme-Linked Immunospot AssayFemaleHIV InfectionsHost-Pathogen InteractionsHumansInterferon-gammaInterferon-gamma Release TestsKineticsLeukocytes, MononuclearLinear ModelsLogistic ModelsMalawiMaleOdds RatioPredictive Value of TestsProspective StudiesSputumTreatment OutcomeTuberculosis, PulmonaryWilkinson, R U117588499Microbiology11 Medical and Health Sciences